The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letters to the EditorFull Access

Dr. Siever Replies

To the Editor: I indeed thank Dr. Terao for the thought-provoking comments. As Dr. Terao explicitly notes, the overview did not attempt to comprehensively review treatment for aggression, nor did it address suicide. However, I agree that lithium may decrease limbic irritability, as do anticonvulsants, and increase “top-down brakes,” perhaps in part by enhancing serotonergic activity (1) . There is indeed limited evidence that lithium is superior to anticonvulsants in the prevention of suicide (2) , although a suicide-protective effect was not found in the data for 4,360 bipolar patients in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (3) .

Bronx, N.Y.

The author’s disclosures accompany the original article.

This letter (doi: 10.1176/appi.ajp.2008.08040598r) was accepted for publication in June 2008.

References

1. Birkenhager TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA: Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1084–1088Google Scholar

2. Sondergard L, Lopez AG, Andersen PK, Kessing LV: Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008; 10:87–94Google Scholar

3. Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME: Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry 2008; 8:e1–e7Google Scholar